Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albrecht Piiper

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
American Journal of Physiology. Cell Physiology|January 15, 2024
BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytesLucia Alcober-Boquet, Nico Kraus, Lisa Sophie Huber, et al.
The EMBO Journal|November 18, 2006
Allosteric activation of the protein kinase PDK1 with low molecular weight compoundsMatthias Engel, Valerie Hindie, Laura A Lopez-Garcia, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 1, 2014
Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imagingIna Rosenberger, Christian Schmithals, Jennifer Vandooren, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Neoplasia (New York, N.Y.)|June 30, 2012
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levelsJörg Haupenthal, Verena Bihrer, Huedayi Korkusuz, et al.
ACS Chemical Biology|January 4, 2017
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C IsoformsJose M Arencibia, Wolfgang Fröhner, Magdalena Krupa, et al.
Oncotarget|January 23, 2016
TGF-β1 and TGF-β2 abundance in liver diseases of mice and menAnne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Cancer Research|August 5, 2015
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular CarcinomaChristian Schmithals, Verena Köberle, Hüdayi Korkusuz, et al.
Plos One|November 9, 2011
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinomaVerena Bihrer, Oliver Waidmann, Mireen Friedrich-Rust, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Physiology. Cell Physiology|January 15, 2024
BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytesLucia Alcober-Boquet, Nico Kraus, Lisa Sophie Huber, et al.
The EMBO Journal|November 18, 2006
Allosteric activation of the protein kinase PDK1 with low molecular weight compoundsMatthias Engel, Valerie Hindie, Laura A Lopez-Garcia, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 1, 2014
Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imagingIna Rosenberger, Christian Schmithals, Jennifer Vandooren, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Neoplasia (New York, N.Y.)|June 30, 2012
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levelsJörg Haupenthal, Verena Bihrer, Huedayi Korkusuz, et al.
ACS Chemical Biology|January 4, 2017
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C IsoformsJose M Arencibia, Wolfgang Fröhner, Magdalena Krupa, et al.
Oncotarget|January 23, 2016
TGF-β1 and TGF-β2 abundance in liver diseases of mice and menAnne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal TransitionAhmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Cancer Research|August 5, 2015
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular CarcinomaChristian Schmithals, Verena Köberle, Hüdayi Korkusuz, et al.
Plos One|November 9, 2011
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinomaVerena Bihrer, Oliver Waidmann, Mireen Friedrich-Rust, et al.
Pageof 8